Witty at OPPI: 'Its only a billion dollars because we fail too often'
This article was originally published in Scrip
Executive Summary
OPPI (Organisation of Pharmaceutical Producers of India) annual general meetings over the years have seen many a keynote speaker highlight how Big Pharma invests huge sums in discovery research and why only a robust IPR regime would help them recoup investments and prevent a free ride by generic firms.